Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-18 for Oral Mucositis in Head and Neck Cancer
NCT03200340Phase 2Completed
- Sponsor
- Enzychem Lifesciences
- Start
- Jul 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosedipimod in oral mucositis (OM), sponsored by Enzychem Lifesciences. Started Jul 2018; status: completed.
02
Drugs
mosedipimod
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03200340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200340.